PBX1 and cancer: In summary, in most types of cancer, PBX1, 2 and 3 act as an oncoproteins to contribute to cancer progression by promoting drug resistance, CSC‐like phenotypes, proliferation, cell cycle, EMT, invasion and metastasis as well as angiogenesis, and by inhibiting apoptosis.